News
Avicenna provides feedback on the processing of personal health data in the EU
During the month of July, the Avicenna Alliance received the opportunity to provide its contribution to the European Commission Survey on the processing of personal health data in the EU. The Commission aimed to examine in which manners the processing of personal health data is governed across EU Member States and how this might affect the cross-border change of health data in the EU in light of the General Data Protection Regulation (GDPR).
The European Medicines Agency has accepted the Avicenna Alliance's request to be directly involved in Agency activities
We are proud to announce that the European Medicines Agency (EMA) has accepted the Avicenna Alliance's request to be directly involved in Agency activities! This is a great opportunity for the Avicenna Alliance to take part in discussions and initiatives initiated by EMA to promote efficient solutions in response to ongoing and future healthcare challenges.
The Avicenna Alliance provided feedback on the Pharmaceutical Strategy for Europe
We are proud to announce that the Avicenna Alliance has submitted Members’ feedback to the European Commission’s Roadmap on the Pharmaceutical Strategy for Europe!
The European Commission, EMA and FDA held their 2020 bilateral regulatory dialogue meeting on 18 and 19 June
Senior Officials from the European Commission (DG SANTE), European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) held their 2020 bilateral regulatory dialogue meeting on 18 and 19 June.
Avicenna publishes provisional executive summary on “The role of Artificial Intelligence within in silico medicine” and comments on the European Commission’s White Paper on AI
On 12 June, the Avicenna Alliance has submitted Members’ feedback through the European Commission’s public consultation on its White Paper on artificial intelligence and released a new publication on the role of Artificial Intelligence within in silico medicine.
The Avicenna Alliance publishes a brand-new position paper on AI & Big Data while providing feedback on the European Strategy for Data
We are proud to announce that on 29 May, the Avicenna Alliance has submitted Members’ feedback to the European Commission’s public consultation on the European Strategy for Data. While providing Members’ feedback to the Commission’s survey on Data, the Alliance has released a brand-new position paper on “AI and Big Data effective readiness, a privacy-enhancing pathway to data access” which has been developed by members of the Avicenna Alliance from medtech, pharmaceutical, software and life science industries and scientific community from academia. This position paper applies both to the Public Consultations on a European Strategy for Data and the White Paper on Artificial Intelligence and constitutes the starting point for a much-needed discussion on how the policy framework governing AI & Data in the health care sector.
